Infection probability score, APACHE II and KARNOFSKY scoring systems as predictors of infection onset in haematology-oncology patients

Journal of Clinical Nursing

Volumn 19, Issue 11-12, 2010, Pages 1560-1568

  Apostolopolou, Eleni ^a   Raftopoulos, Vasilios ^b   Terzis, Konstantinos ^c   Pissaki, Kiriaki ^d   Pagoni, Maria ^d   Delibasi, Sossana ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^c Halkida General Hospital   (Greece)

^d IASO GENERAL HOSPITAL   (Greece)

Author keywords

APACHE II; Haematology; Healthcare associated infections; Infection Probability Score; KARNOFSKY; Nursing

Indexed keywords

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASM; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; COMPLICATION; HEMATOLOGIC DISEASES; NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; FEMALE; HEMATOLOGIC DISEASES; HUMANS; INFECTION; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77955972490     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2009.03011.x     Document Type: Article

References (35)

1. Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma and multiple myeloma. Annals of Hematology 2002, 81:374-377.
2. Bow E. Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. Journal of Antimicrobial Chemotherapy 1998, 41(Suppl. D):1-5.
3. Carlisle S, Gucalp R, Wiernik H. Nosocomial infections in neutropenic cancer patients. Infection Control and Hospital Epidemiology 1933, 14:320-324.
4. Contoyiannis P, Rubin H. Infection in the organ transplant recipient. An overview. Infectious Disease Clinics of North America 1995, 9:811-822.
5. Cosic G, Lukic N, Miladinov-Mikov M. Hospital-acquired infections at the Institute of Oncology Sremska Kamenica. Archives of Oncology 2000, 8:185-186.
6. Engelhart S, Glasmacher A, Exner M, Kramer M. Surveillance for Nosocomial Infections and Fever of Unknown Origin among Adult Hematology-Oncology Patients. Infection Control and Hospital Epidemiology 2002, 23:244-248.
7. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. Journal of Hospital Infection 2004, 57:316-320.
8. 2008, European Centre for Disease Prevention and Control, Annual Epidemiological Report on communicable diseases in Europe. Report on the status of communicable diseases in the EU and EEA/EFTA countries
9. Gifford A, Kirkland K. Risk factors for Clostridium difficile associated diarrhea on an adult hematology- oncology ward. European Journal of Clinical Microbiology & Infectious Diseases 2006, 25:751-755.
10. Gonzalez-Barca E, Caratalla J, Mykietiuk A, Fernández-Sevilla A, Gudiol F. Predisposing factors and outcome of staphylococcus aureus bacteremia in neutropenic patients with cancer. European Journal of Clinical Microbiology & Infectious Diseases 2001, 20:117-119.
11. Prevention of bacterial infection in neutropenic patients with hematologic malignancies: a randomised, multicenter trial comparing norfloxacin with ciproflaxin. Annals of Internal Medicine 1991, 115:7-12. Gruppo Italiano malattie emayologiche maligne dell' adult
12. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. American Journal of Infection Control 1997, 25:112-116.
13. Hughes T, Armsrong D, Bodey P. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clinical Infectious Diseases 1997, 25:551-573.
14. Karnofsky DA, Burchanot JH. The Clinical Evaluation of Chemotherapeutic Agents 1949, New York Columpia Univ. Press, New York
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985, 13:818-829.
16. Laws HJ, Kobbe G, Dilloo D, Dettenkofer M, Meisel R, Geisel R, Haas R, Gobel U, Schulze-Robbecke R. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. Journal of Hospital Infection 2006, 62:80-88.
17. Martini A, Gottin L, Melot C, Vincent JL. A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit. Journal of Infection 2008, 56:313-318.
18. Massion P, Dive A, Doyen C, Bulpa P, Jamart J, Bosly A, Installé E. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Critical Care Medicine 2002, 30:2260-2270.
19. Nucci M, Silveira I, Velasco E, Akiti T, Barreiros G, Derossi A, Colombo AL, Pulcheri W. Risk factors for death among cancer patients with fungemia. Clinical Infectious Diseases 1998, 27:107-111.
20. Penack O, Rempf P, Eisenblatter M, Stroux A, Wagner J, Thiel E, Blau IW. Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Annals of Oncology 2007, 5:1-5.
21. Peres-Bota D, Melot C, Lopes Ferreira F, Vincent JL. Infection Probability Score (IPS): a simple method to help assess the probability of infection in critically patients. Critical Care Medicine 2003, 31:2579-2584.
22. Pittet D, Tarara D, Wenzel R. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs and attributable mortality. JAMA 1994, 271:1598-1601.
23. Pizo PA. Management of fever in patients with cancer and chemotherapy induced neutropenia. The New England Journal of medicine 1993, 328:1323-1332.
24. Rotstein C, Cummings KM, Nicolaou AL, Lucey J, Fitzpatrick J. Nosocomial infection rates at an oncology center. Infection Control 1988, 9:13-19.
25. Rutala W, Weber D. CDC guideline for disinfection and sterilisation in health-care facilities 2008, the Healthcare Infection Control Practices Advisory Committee (HICPAC), CDC, Atlanta
26. Safavi M, Honarmand A. Comparison of infection probability score, APACHE II and APACHE III Scoring Systems in Predicting Need for Ventilator and Ventilation Duration in Critically Ill Patients. Archives of Iranian Medicine 2007, 10:354-360.
27. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity and guidelines. Journal of Clinical Oncology 1984, 2:187-193.
28. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infection Control and Hospital Epidemiology 2000, 21:592-596.
29. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infectious Diseases 2008, 8:70.
30. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991, 100:164-167.
31. Sugahara H, Mizuki M, Matsumae S, Nabetani Y, Kikuchi M, Kanakura Y. Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies. Infection Control and Hospital Epidemiology 2004, 25:51-54.
32. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. The Journal of Experimental Medicine 1930, 52:561-571.
33. Urrea M, Rives S, Cruz O, Navarro A, Garcia JJ, Estella J. Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study. American Journal of Infection Control 2004, 32:205-208.
34. Velasco E, Byington R, Martins CAS, Schirmer M, Dias LMC, Gonçalves VMSC. Prospective evaluation of the epidemiology, microbiology and outcome of blood stream infections in hematologic patients in a single cancer center. European Journal of Clinical Microbiology & Infectious Diseases 2003, 22:137-143.
35. Wisplinghoff H, Cornely O, Moser SBetheU, Stützer H, Salzberger B, Fätkenheuer G, Seifert H. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infection Control and Hospital Epidemiology 2003, 24:905-911.